Brought to you by
ECR 2018 / C-1592
MR enterography-our experience. Is it the future ?
Congress: ECR 2018
Poster No.: C-1592
Type: Educational Exhibit
Keywords: Abdomen, Gastrointestinal tract, MR, Diagnostic procedure, Pathology
Authors: C. A. B. Oliveira1, F. M. F. Gomes2, G. Rio3, T. Dionisio1, V. Mendes1; 1Braga/PT, 2Vila Nova de Sande/PT, 3Gondomar/PT



1.     Triester SL, Leighton JA, Leontiadis GI, et al. A meta- analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn’s disease. Am J Gastroenterol 2006;101(5): 954–964.
2.     Langan RC, Gotsch PB, Krafczyk MA, Skillinge DD. Ul- cerative colitis: diagnosis and treatment. Am Fam Physician 2007;76(9):1323–1330.
3.     Furukawa A, Saotome T, Yamasaki M, et al. Cross-sectional imaging in CD. RadioGraphics 2004;24(3):689–702.
4.     Amzallag-Bellenger E, Oudjit A, Ruiz A, Cadiot G, Soyer PA, Hoeffel CC. Effectiveness of MR enterography for the assessment of small-bowel diseases beyond CD. RadioGraph- ics 2012;32(5):1423–1444.
5.     Scholz FJ, Humphrey PE. Crohn’s disease. In: Levy AD, Mortele KJ, Yeh BM, eds. Gastrointestinal imaging. Oxford, England: Oxford University Press, 2015; 136–141.
6.     Wilkins T, Jarvis K, Patel J. Diagnosis and management of Crohn’s disease. Am Fam Physician 2011;84(12): 1365–1375.
7.     Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. J Am Med Assoc 1932;99(16):1323–1329.
8.     Sands BE, Siegel CA. Crohn’s disease. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. 10th ed. Philadelphia, Pa: Elsevier Health Sci- ences, 2015; 1990–2022.
9.     Gore RM, Berlin JW, Ivanovic AM. Ulcerative and granu- lomatous colitis: idiopathic in ammatory bowel disease. In: Gore RM, Levine MS, eds. Textbook of gastrointes- tinal radiology. 4th ed. Philadelphia, Pa: Elsevier: 2015; 984–1016.
10. Ephgrave K. Extra-intestinal manifestations of Crohn’s disease. Surg Clin North Am 2007;87(3):673–680.
11. Maglinte DD, Gourtsoyiannis N, Rex D, Howard TJ, Kelvin FM. Classi cation of small bowel Crohn’s subtypes based on multimodality imaging. Radiol Clin North Am 2003;41(2):285–303.
12. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Ya FA, Belaiche J. Behaviour of Crohn’s disease according to the Vienna classi cation: changing pattern over the course of the disease. Gut 2001;49(6):777–782.
13. Burke JP, Mulsow JJ, O’Keane C, Docherty NG, Watson RW, O’Connell PR. Fibrogenesis in Crohn’s disease. Am J Gastroenterol 2007;102(2):439–448.
14. Liu JK, Lichtenstein GR. In ammatory bowel disease. In: Ginsberg GG, Gostout CJ, Kochman ML, Norton ID, eds. Clinical gastrointestinal endoscopy. 2nd ed. St Louis, Mo: Elsevier Saunders, 2012; 243–264.
15. 24. Sinha R, Rajiah P, Murphy P, Hawker P, Sanders S. Utility of high-resolution MR imaging in demonstrating transmural pathologic changes in CD. RadioGraphics 2009;29(6): 1847–1867.
16. 25. Sempere GA, Martinez Sanjuan V, Medina Chulia E, et al. MRI evaluation of in ammatory activity in Crohn’s disease. AJR Am J Roentgenol 2005;184(6):1829–1835.
17. 26. Punwani S, Rodriguez-Justo M, Bainbridge A, et al. Mural in ammation in CD: location-matched histologic valida- tion of MR imaging features. Radiology 2009;252(3): 712–720.
18. Rimola J, Planell N, Rodríguez S, et al. Characterization of in ammation and brosis in Crohn’s disease lesions by magnetic resonance imaging. Am J Gastroenterol 2015;110(3):432–440.
19. Carbo AI, Reddy T, Gates T, Vesa T, Thomas J, Gonzalez E. The most characteristic lesions and radiologic signs of CD of the small bowel: air enteroclysis, MDCT, endoscopy, and pathology. Abdom Imaging 2014;39(1):215–234.
20. Herlinger H, Furth EE, Rubesin SE. Fibrofatty prolifera- tion of the mesentery in CD. Abdom Imaging 1998;23(4): 446–448.
21. Tielbeek JA, Makanyanga JC, Bipat S, et al. Grading CD activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with CD endoscopic index of severity. AJR Am J Roentgenol 2013;201(6):1220–1228.
22. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn’s disease. In amm Bowel Dis 2002;8(4):244–250.
23. Li C, Kuemmerle JF. Mechanisms that mediate the develop- ment of brosis in patients with Crohn’s disease. In amm Bowel Dis 2014;20(7):1250–1258.
24. Siegel CA. Risk of lymphoma in in ammatory bowel disease. Gastroenterol Hepatol (N Y) 2009;5(11):784–790.
25. Wilks S. Morbid appearances in the intestines of Miss Bankes. Med Times Gaz 1859;2:264–265.
26. Osterman MT, Lichtenstein GR. Ulcerative colitis. In: Brandt LJ, Feldman M, Friedman LS, eds. Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. 10th ed. Philadelphia, Pa: Elsevier Health Sciences, 2015; 2023–2061.
27. Adams SM, Bornemann PH. Ulcerative colitis. Am Fam Physician 2013;87(10):699–705.
28. Gore RM, Balthazar EJ, Ghahremani GG, Miller FH. CT features of ulcerative colitis and Crohn’s disease. AJR Am J Roentgenol 1996;167(1):3–15.
29. Laghi A, Paolantonio P, Iafrate F, Altomari F, Miglio C, Passariello R. Oral contrast agents for magnetic resonance imaging of the bowel. Top Magn Reson Imaging 2002;13:389–396.
30. Rieber A, Aschoff A, Nussle K, et al. MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol 2000;10:1377–1382.

POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more